ChiCTR2100043631 版本V1.5 版本创建时间2021/06/19 21:42:43 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2100043631 

最近更新日期:

Date of Last Refreshed on:

2021-06-19 21:37:21 

注册时间:

Date of Registration:

2021-02-23 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

陈洪锁医师:请于我们联系上传该试验伦理审批文件并填写审批日期。 Stretta 与经口内镜下贲门缩窄术治疗胃食管反流病的疗效分析 —临床对照研究

Public title:

Efficacy analysis of Stretta and oral endoscopic stenosis for gastroesophageal reflux disease: a clinical controlled study

注册题目简写:

English Acronym:

研究课题的正式科学名称:

Stretta 与经口内镜下贲门缩窄术治疗胃食管反流病的疗效分析 —临床对照研究

Scientific title:

Efficacy analysis of Stretta and oral endoscopic stenosis for gastroesophageal reflux disease: a clinical controlled study

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

陈洪锁 

研究负责人:

孟宪梅 

Applicant:

Hongsuo Chen 

Study leader:

Xian mei Meng 

申请注册联系人电话:

Applicant telephone:

+86 13848219810

研究负责人电话:

Study leader's
telephone:

+86 18647235576

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

80849649@qq.com

研究负责人电子邮件:

Study leader's E-mail:

mxmxhk@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

内蒙古包头市青山区呼得木林大街30号

研究负责人通讯地址:

内蒙古包头市青山区呼得木林大街30号

Applicant address:

30 Hude Mulin Street, Qingshan District, Baotou, Inner Mongolia

Study leader's address:

30 Hude Mulin Street, Qingshan District, Baotou, Inner Mongolia

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

内蒙古科技大学包头医学院第二附属医院

Applicant's institution:

Inner Mongolia University of Science and Technology, Baotou Medical College Second Affiliated Hospital

研究负责人所在单位:

内蒙古科技大学包头医学院第二附属医院

Affiliation of the Leader:

Inner Mongolia University of Science and Technology, Baotou Medical College Second Affiliated Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2019年科伦审第(ZX-012)

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

包头医学院第二附属医院医学伦理委员会

Name of the ethic committee:

Baotou Medical College Second Affiliated Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

1990-01-01 00:00:00

伦理委员会联系人:

黄冠华

Contact Name of the ethic committee:

Guanhua Huang

伦理委员会联系地址:

内蒙古包头市青山区呼得木林大街30号

Contact Address of the ethic committee:

30 Hude Mulin Street, Qingshan District, Baotou, Inner Mongolia

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

内蒙古科技大学包头医学院第二附属医院

Primary sponsor:

Inner Mongolia University of Science and Technology Baotou Medical College Second Affiliated Hospita

研究实施负责(组长)单位地址:

内蒙古包头市青山区呼得木林大街30号

Primary sponsor's address:

30 Hude Mulin Street, Qingshan District, Baotou, Inner Mongolia

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

内蒙

市(区县):

包头

Country:

China

Province:

Inner Mongolia

City:

Baotou

单位(医院):

内蒙古科技大学包头医学院第二附属医院

具体地址:

青山区呼得木林大街30号

Institution
hospital:

Inner Mongolia University of Science and Technology Baotou Medical College Second Affiliated Hospital

Address:

30 Hude Mulin Street, Qingshan District

经费或物资来源:

自筹

Source(s) of funding:

self-raised

研究疾病:

胃食管反流病  

Target disease:

Gastroesophageal reflux disease

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

1、分析GERD患者Stretta、PECC术后临床症状缓解程度; 2、分析GERD患者Stretta、PECC术后胃食管连接处压力数值的变化; 3、分析GERD患者Stretta、PECC术后胃食管反流客观数值的变化; 4、分析GERD患者Stretta、PECC术后焦虑、抑郁评分的变化。  

Objectives of Study:

Analysis of clinical symptom relief after Stretta and PECC in patients with GERD; Analysis of changes in pressure values of gastroesophageal junction after Stretta and PECC in patients with GERD; Analysis of changes in objective values of gastroesophageal reflux after Stretta and PECC in patients with GERD; Analysis of changes in anxiety and depression scores after Stretta and PECC in patients with GERD.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)临床诊断(具有的烧心、反酸症状);
(2)24h食管pH-阻抗监测符合 Demeester 评分>14.72,或存在病理性弱酸反流或弱碱反流;
(3)以PPI为主治疗2个月以上,症状缓解不明显或者缓解后仍反复发作;
(4)根据阀瓣分级内镜下诊断为II级的患者,即贲门松弛但尚未达到食管裂孔疝诊断标准。

Inclusion criteria

(1) Clinical diagnosis (with heartburn, acid reflux symptoms);
(2) 24h esophageal pH-impedance monitoring in accordance with Demeester score > 14.72, or pathological weak acid reflux or weak base reflux;
(3) PPI-based After treatment for more than 2 months, the symptoms were not relieved or repeated after remission;
(4) According to the classification of the valve, the endoscopic diagnosis was grade II, that is, the cardia was slack but the diagnostic criteria for esophageal hiatus were not reached.

排除标准:

(1)病理活检证实为 Barrett 食管或早癌患者;
(2)曾接受过胃折叠术等外科手术治疗的患者、正常生理解剖结构已破坏的患者;
(3)食管裂孔疝,即LES-CD分离>2cm;
(4)严重心肺疾病患者。
注意:反流性食管炎不纳入治疗,药物治疗黏膜愈合后可纳入研究。

Exclusion criteria:

(1) Patients with Barrett's esophagus or early cancer confirmed by pathological biopsy;
(2) Patients who have undergone surgical treatment such as gastric folding surgery, patients whose normal physiological anatomy has been destroyed;
(3) Esophageal hiatus hernia, ie LES-CD Separation > 2cm;
(4) Patients with severe cardiopulmonary disease.Note: Reflux esophagitis is not included in the treatment, and drug treatment can be included in the study after mucosal healing.

研究实施时间:

Study execute time:

From 2021-02-15 00:00:00 To 2021-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-02-15 00:00:00 To 2021-12-31 00:00:00

干预措施:

Interventions:

组别:

Stretta治疗组;PECC治疗组

样本量:

50

Group:

Stretta Group;PECC Group

Sample size:

干预措施:

内镜治疗

干预措施代码:

Intervention:

Endoscopic treatment

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

内蒙古 

市(区县):

 

Country:

China

Province:

Inner Mongolia

City:

单位(医院):

内蒙古科技大学包头医学院第二附属医院 

单位级别:

三级综合医院 

Institution
hospital:

Inner Mongolia University of Science and Technology Baotou Medical College Second Affiliated Hospital

Level of the institution:

Tertiary general hospital

测量指标:

Outcomes:

指标中文名:

术后疗效

指标类型:

主要指标

Outcome:

Postoperative

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

食管黏膜

组织:

Sample Name:

Esophageal mucosa

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 40 years
最大 Max age 65 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

门诊医生或病房接诊医生评估后,拟行内镜下Stretta或PECC治疗,术前完善(基本在评估过程中已完成):1.GerdQ量表或RDQ量表;2.食管压力测定及24小时食管MII-pH监测;3.焦虑-抑郁量表; 2.结合患者意愿、选择内镜下治疗方法,并进行术后1周、术后1月、术后3月、术后6月、术后12月分别进行随访。

Randomization Procedure (please state who generates the random number sequence and by what method):

After evaluation by the outpatient doctor or ward attending doctor, endoscopic Stretta or PECC treatment is planned, preoperatively perfected (basically completed during the evaluation process): 1. GerdQ scale or RDQ scale; 2. Esophageal pressure measurement and 24 Hour esophageal MII-pH monitoring; 3. Anxiety-depression scale

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2022.6

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

June 2022

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病历记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Medical Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2021-02-23 13:11:13